Drug-Induced Hepatotoxicity
The DOI matches its Crossref record; 182 of the 182 references it cites were found in a registry or an index.
Abstract
Drug-induced hepatic injury accounts for more than 50 percent of cases of acute liver failure in the United States. More than 75 percent of idiosyncratic drug reactions result in liver transplantation or death. This review discusses the pathogenesis of drug-induced liver injury, common adverse drug reactions involving the liver, and the drug-approval process. Monitoring for and recognition of drug-induced hepatotoxicity may prevent some cases of acute hepatic failure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is known that many variables, such as genetic variability, race, sex, age, metabolic capacity, drug-drug interactions, and preexisting diseases, contribute to individual susceptibility and toxicity of idiosyncratic drugs (Lee, 2003).”
From Mitochondrial Dysfunction Induced by Sertraline, an Antidepressant Agent (2012) · cites this paper as Lee, 2003
In the citing paper
“Under these limited conditions, two-dimensional (2D) monolayered cells exhibit altered biological features, including morphology, function, hepatic polarity, and genotype expression (Lasser et al., 2002;Lee, 2003;Ma et al., 2023).”
From Fast formation and maturation enhancement of human liver organoids using a liver-organoid-on-a-chip (2024) · cites this paper as Lee, 2003
Citations
Cites
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807
Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227
Self-citationEarly indicators of prognosis in fulminant hepatic failure
O'Grady, J. G., Alexander, G. J. M., Hayllar, K. M., & Williams, R. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90081-4 · Cited by 2,085
ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. IV. PROTECTIVE ROLE OF GLUTATHIONE
Mitchell, J. R., Jollow, D. J., Potter, W. Z., Gillette, J. R., & Brodie, B. B. (1973) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29666-5 · Cited by 1,737
Role of Quinones in Toxicology
Bolton, J. L., Trush, M. A., Penning, T. M., Dryhurst, G., & Monks, T. J. (2000) · Chemical Research in Toxicology · doi:10.1021/tx9902082 · Cited by 1,703
Common and Uncommon Cytochrome P450 Reactions Related to Metabolism and Chemical Toxicity
Guengerich, F. P. (2001) · Chemical Research in Toxicology · doi:10.1021/tx0002583 · Cited by 1,655
Danan, G., & Benichou, C. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90101-6 · Cited by 1,481
Jaeschke, H. (2002) · Toxicological Sciences · doi:10.1093/toxsci/65.2.166 · Cited by 1,304
McDonald, G. B., Hinds, M. S., Fisher, L. D., Schoch, H. G., Wolford, J. L., Banaji, M., Hardin, B. J., Shulman, H. M., & Clift, R. A. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-4-199302150-00003 · Cited by 1,202
Efficacy of Oral N-Acetylcysteine in the Treatment of Acetaminophen Overdose
Smilkstein, M. J., Knapp, G. L., Kulig, K. W., & Rumack, B. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812153192401 · Cited by 1,102
Research works printed but not linked: 9
- Yun CH, 1993, Drug Metab Dispos, 21, 403
- Chitturi S, 2001, Semin Gastrointest Dis, 12, 113
- Wang K, 1999, Zhonghua Yi Xue Za Zhi (Taipei), 62, 369
- George J, 1995, Hepatology, 21, 120
- Meadows M, 2001, FDA Consum, 35, 8
- Piliero PJ, 2001, AIDS Read, 11, 379
- 10.1111/j.1572-0241.1999.01091.x · doi:10.1111/j.1572-0241.1999.01091.x · Paper page
- Fernandes NF, 2000, Am J Gastroenterol, 95, 532, 10.1111/j.1572-0241.2000.t01-1-01780.x · doi:10.1111/j.1572-0241.2000.t01-1-01780.x · Paper page
- Graham DJ, 2002, Hepatology, 36, 168A
Cited by
Items 601–700 of 1,000
Asgarshirazi, M., Shariat, M., & Sheikh, M. (2017) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(16)60142-x · Cited by 28
Granitzny, A., Knebel, J., Schaudien, D., Braun, A. C., Steinberg, P., Dasenbrock, C., & Hansen, T. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.05.001 · Cited by 28
Arafa, M. H., & Atteia, H. H. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.03.019 · Cited by 28
Three-Level Hepatotoxicity Prediction System Based on Adverse Hepatic Effects
Liu, L., Fu, L., Zhang, J., Wei, H., Ye, W.-L., Deng, Z., Zhang, L., Cheng, Y., Ouyang, D., Cao, Q., et al. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01048 · Cited by 29
Kon, R. H., Russo, M. W., Ory, B., Mendys, P., & Simpson, R. J. (2008) · Journal of clinical lipidology · doi:10.1016/j.jacl.2008.01.002 · Cited by 28
Makar, G. A., Weiner, M. G., Kimmel, S. E., Bennett, D., Burke, A., Yang, Y., Han, X., Sellers, K. F., Nessel, L. A., & Lewis, J. D. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1514 · Cited by 28
Anesthesia and the Hepatobiliary System
Rothenberg, D. M., O’Connor, C. J., & Tuman, K. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06959-8.00066-2 · Cited by 30
Hepatitis Associated with Low-Dose Venlafaxine for Postmenopausal Vasomotor Symptoms
Phillips, B., Digmann, R., & Beck, M. G. (2006) · The Annals of Pharmacotherapy · doi:10.1345/aph.1g339 · Cited by 27
Ethnically diverse pluripotent stem cells for drug development
Fakunle, E. S., & Loring, J. F. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.10.007 · Cited by 27
Impairment of triptolide on liver mitochondria in isolated liver mitochondria and HL7702 cell line
Fu, Q., Jiang, Z., & Zhang, L. (2013) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-012-1265-x · Cited by 27
Sultana, N., Shimmi, S. C., Parash, M. T. H., & Akhtar, J. (2012) · Journal of Bangladesh Society of Physiologist · doi:10.3329/jbsp.v7i1.11152 · Cited by 27
El‐Garawani, I. M., Khallaf, E. A., Alne-na-ei, A. A., Elgendy, R. G., Sobhy, H. M., Khairallah, A., Hathout, H. M. R., Malhat, F. M., & Nofal, A. E. (2022) · Bulletin of Environmental Contamination and Toxicology · doi:10.1007/s00128-022-03611-6 · Cited by 27
Pandey, B., Thapa, S., Kaundinnyayana, A., & Panta, S. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4288 · Cited by 33
Drugs of abuse and addiction: A slippery slope toward liver injury
Roy, D. N., & Goswami, R. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.09.018 · Cited by 29
Protective effects of sodium molybdate on carbon tetrachloride-induced hepatotoxicity in rats
Eidi, A., Eidi, M., Ale‐Ebrahim, M., Rohani, A. H., & Mortazavi, P. (2011) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2010.12.003 · Cited by 27
Hepatic adverse drug reactions: a case/non-case study in Italy
Motola, D., Vargiu, A., Leone, R., Cocci, A., Salvo, F., Ros, B. Z., Meneghelli, I., Venegoni, M., Cutroneo, P. M., Vaccheri, A., et al. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-006-0222-z · Cited by 27
Drug-induced acute liver failure and gastrointestinal complications
Lat, I., Foster, D. R., & Erstad, B. L. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181de0db2 · Cited by 31
Quantitative intravital microscopy of hepatic transport
Babbey, C. M., Ryan, J., Gill, E. M., Ghabril, M., Burch, C. R., Paulman, A., & Dunn, K. W. (2012) · IntraVital · doi:10.4161/intv.21296 · Cited by 27
Autophagy in drug-induced liver toxicity
Chen, S., Melchior, W. B., Wu, Y., & Guo, L. (2014) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2014.03.007 · Cited by 28
Pancreatitis following Olanzapine Therapy: A Report of Three Cases
Kerr, T. A., Jonnalagadda, S. S., Prakash, C., & Azar, R. R. (2007) · Case Reports in Gastroenterology · doi:10.1159/000104222 · Cited by 27
Herbal hepatotoxicity and WHO global introspection method
Teschke, R., Eickhoff, A., Wolff, A., Frenzel, C., & Schulze, J. (2013) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31380-8 · Cited by 27
Zhang, R., Takebe, T., Miyazaki, L., Takayama, M., Koike, H., Kimura, M., Enomura, M., Zheng, Y., Sekine, K., & Taniguchi, H. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1435-7_10 · Cited by 30
Hosoya, M., & Czysz, K. (2016) · Cells · doi:10.3390/cells5040046 · Cited by 27
Jackson, J. P., Freeman, K., Claire, R. L. S., Black, C., & Brouwer, K. R. (2018) · Applied In Vitro Toxicology · doi:10.1089/aivt.2018.0011 · Cited by 29
Elaziz, M. A., Moemen, Y. S., Hassanien, A. E., & Xiong, S. (2019) · Applied Soft Computing · doi:10.1016/j.asoc.2019.105509 · Cited by 27
Clinical Hepatotoxicity. Regulation and Treatment with Inducers of Transport and Cofactors
Marschall, H., Wagner, M., Zollner, G., & Trauner, M. (2007) · Molecular Pharmaceutics · doi:10.1021/mp060133c · Cited by 31
Anastrozole-induced hepatotoxicity
Zapata, E. M., Zubiaurre, L., Bujanda, L., & rola, A. P. (2006) · European Journal of Gastroenterology & Hepatology · doi:10.1097/01.meg.0000243868.64078.af · Cited by 27
Assessment of treatment efficacy in HBV infection and disease
Zoulim, F. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.11.020 · Cited by 28
CASE REPORT: Hepatic Injury Due to Troglitazone
Malik, A. H., Prasad, P. V. L. N. S., Saboorian, M. H., Thiele, D. L., & Malet, P. F. (2000) · Digestive Diseases and Sciences · doi:10.1023/a:1005450519498 · Cited by 27
Yano, A., Oda, S., Fukami, T., Nakajima, M., & Yokoi, T. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.04.005 · Cited by 26
A microfluidic thyroid-liver platform to assess chemical safety in humans
Kuehnlenz, J., Karwelat, D., Steger‐Hartmann, T., Raschke, M., Bauer, S., Vural, Ö., Marx, U., Tinwell, H., & Bars, R. (2022) · ALTEX · doi:10.14573/altex.2108261 · Cited by 29
Wang, F., Wen, T., Chen, X.-Y., & Wu, H. (2008) · Inflammation Research · doi:10.1007/s00011-007-7153-8 · Cited by 27
Kuribayashi, S., Goto, K., Naito, S., Kamataki, T., & Yamazaki, H. (2009) · Chemical Research in Toxicology · doi:10.1021/tx8003592 · Cited by 27
Tiwari, V., Singh, M., Rawat, J. K., Devi, U., Yadav, R. K., Roy, S., Gautam, S., Saraf, S. A., Kumar, V., Ansari, N. M., et al. (2016) · Inflammopharmacology · doi:10.1007/s10787-016-0274-3 · Cited by 29
Clinical and histologic features of Azathioprine-induced hepatotoxicity
Siramolpiwat, S., & Sakonlaya, D. (2017) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2017.1311936 · Cited by 26
Afsar, T., Razak, S., Almajwal, A. M., & Khan, M. R. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1824-y · Cited by 26
Olawale, F., Iwaloye, O., & Elekofehinti, O. O. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1991476 · Cited by 27
The release of DNA into the plasma of mice following hepatic cell death by apoptosis and necrosis
Tran, T. T., Groben, P. A., & Pisetsky, D. S. (2008) · Biomarkers · doi:10.1080/13547500701791719 · Cited by 28
Hepatotoxicity induced by clopidogrel
Beltrán-Robles, M., Saavedra, E. M., Sánchez-Muñoz, D., & Romero‐Gómez, M. (2003) · Journal of Hepatology · doi:10.1016/j.jhep.2003.11.013 · Cited by 26
Foie, médicaments et agents chimiques
Larrey, D. G. (2009) · Gastroentérologie Clinique et Biologique · doi:10.1016/j.gcb.2009.10.003 · Cited by 31
Mitochondria, ciglitazone and liver: A neglected interaction in biochemical pharmacology
Scatena, R., Bottoni, P., Martorana, G. E., Vincenzoni, F., Botta, G., Pastore, P., & Giardina, B. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.04.017 · Cited by 28
den Hof, W. F. P. M. V., Summeren, A. V., Lommen, A., Coonen, M. L. J., Brauers, K. J. J., van Herwijnen, M. H. M., Wodzig, W. K. W. H., & Kleinjans, J. C. S. (2014) · Toxicology · doi:10.1016/j.tox.2014.06.003 · Cited by 26
Sun, W., Yan, B., Wang, R., Liu, F., Hu, Z., Zhou, L., Li, Y., Zhou, K., Huang, J., Tong, P., et al. (2018) · EXCLI journal · doi:10.17179/excli2018-1607 · Cited by 25
Drug-induced liver injury and prospect of cytokine based therapy; A focus on IL-2 based therapies
Kumar, N., Surani, S., Udeani, G., Mathew, S., John, S. R., Sajan, S., & Mishra, J. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119544 · Cited by 30
Wang, Z., Ma, J., He, Y., Miu, K.-K., Yao, S., Tang, C., Ye, Y., & Lin, G. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154162 · Cited by 27
Adeneye, A. A., & Olagunju, J. (2010) · African Journal of Biomedical Research · doi:10.4314/ajbr.v11i2.50704 · Cited by 26
Aspirin-Induced Acute Liver Injury
Laster, J., & Satoskar, R. S. (2014) · ACG Case Reports Journal · doi:10.14309/crj.2014.81 · Cited by 25
Tian, G., Zhao, Q., Chen, F., Jiang, T., & Wang, W. (2016) · Oncotarget · doi:10.18632/oncotarget.14030 · Cited by 25
Habs, M. R., Binder, K., Krauß, S., Müller, K., Ernst, B., Valentini, L., & Koller, M. T. (2017) · Nutrients · doi:10.3390/nu9070717 · Cited by 27
Effects of psychopharmacological treatment with antidepressants on the vascular system
Kahl, K. G., Westhoff‐Bleck, M., & Krüger, T. H. C. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2017.07.004 · Cited by 27
Rana, S. V., Ola, R. P., Sharma, S. K., Arora, S. K., Sinha, S. K., Pandhi, P., & Singh, K. (2011) · Hepatology International · doi:10.1007/s12072-011-9309-4 · Cited by 25
Monitoring liver safety in drug development: The GSK experience
Hunt, C. M., Papay, J. I., Edwards, R. I., Theodore, D., Alpers, D., Dollery, C. T., DeBruin, T. W., Adkison, K. K., Stirnadel-Farrant, H. A., & Gibbs, T. (2007) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2007.06.002 · Cited by 27
NAKAGAWA, K., YAMAGAMI, T., & TAKEMURA, N. (2005) · Journal of Veterinary Medical Science · doi:10.1292/jvms.67.1051 · Cited by 25
Acute Liver Failure in Children
Alonso, E. M., Squires, R. H., & Whitington, P. F. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511547409.007 · Cited by 26
Hepatitis aguda ictérica secundaria a kava
Bujanda, L., Palacios, A., Silvariño, R., Sánchez, A., & Muñoz, C. (2002) · Gastroenterología y Hepatología · doi:10.1016/s0210-5705(02)70281-1 · Cited by 25
Concept for Modular Extracorporeal Liver Support for the Treatment of Acute Hepatic Failure
Sauer, I. M., Neuhaus, P., & Gerlach, J. (2002) · Metabolic Brain Disease · doi:10.1023/a:1021938708670 · Cited by 25
Hetta, H. F., Ahmed, E. A., Hemdan, A. M. G., El-Deek, H. E. M., Abd-Elregal, S., & Ellah, N. H. A. (2020) · Nanomedicine · doi:10.2217/nnm-2020-0001 · Cited by 25
Segovia‐Zafra, A., Paz, M. V., Serras, A. S., Matilla‐Cabello, G., Bodoque-García, A., Zeo-Sánchez, D. E. D., Niu, H., Álvarez‐Álvarez, I., Sanz‐Villanueva, L., Godec, S., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.026 · Cited by 25
The role of hepatic cytochrome P-450 in sepsis.
Jacob, A., Zhou, M., Wu, R., & Wang, P. (2009) · PubMed Central · Cited by 28
Non‐Steroidal Anti‐Inflammatory Drugs
Papich, M. G., & Messenger, K. (2015) · Wiley eBooks · doi:10.1002/9781119421375.ch12 · Cited by 28
Tissue slices for the evaluation of metabolism-based toxicity with the example of diclofenac
Vickers, A. E. M. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.10.010 · Cited by 24
Comparison of potentially hepatotoxic drugs among major US drug compendia
Guo, J. J., Wigle, P. R., Lammers, K., & Vu, O. (2005) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2005.06.005 · Cited by 25
Kleiner, D. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-7020-6697-9.00012-1 · Cited by 24
Gülmez, S. E., Ünal, Ü. S., Lassalle, R., Chartier, A., Grolleau, A., & Moore, N. D. (2018) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4640 · Cited by 24
Prescribing in Chronic Severe Hepatic Impairment
Wilcock, A., Charlesworth, S. A., Prentice, W. M., Selby, P., McKenna, M. K., Cripps, S., Considine, A., Orr, A., Wright, M., Mihalyo, M., et al. (2019) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2019.04.034 · Cited by 25
Hetzel, P. G., Glanzmann, R., Hasler, P. W., Ladewick, A., & Bührer, C. (2006) · European Journal of Pediatrics · doi:10.1007/s00431-005-0064-1 · Cited by 24
Safety biomarkers for drug-induced liver injury – current status and future perspectives
Antoine, D. J., Harrill, A. H., Watkins, P. B., & Park, B. K. (2013) · Toxicology Research · doi:10.1039/c3tx50077b · Cited by 28
Cytotoxicity of chloroquine in isolated rat hepatocytes
Jamshidzadeh, A., Niknahad, H., & Kashafi, H. (2007) · Journal of Applied Toxicology · doi:10.1002/jat.1194 · Cited by 24
Hepatoprotective effects of Yulangsan polysaccharide against nimesulide-induced liver injury in mice
Nguyen, V., Huang, J., Doan, V. M., Lin, X., Tang, X., Huang, Y., Tang, A., Yang, X. C., & Huang, R. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.06.048 · Cited by 24
Evaluation of glutathione deficiency in rat livers by microarray analysis
Kiyosawa, N., Ito, K., Sakuma, K., Niino, N., Kanbori, M., Yamoto, T., Manabe, S., & Matsunuma, N. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.053 · Cited by 25
Huo, M. (2011) · Thrombosis and Haemostasis · doi:10.1160/th10-10-0653 · Cited by 25
Srirangan, P., & Prince, S. E. (2025) · Drug and Chemical Toxicology · doi:10.1080/01480545.2025.2455442 · Cited by 37
Modeling the Bioactivation and Subsequent Reactivity of Drugs
Hughes, T. B., Flynn, N. R., Dang, N. L., & Swamidass, S. J. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00417 · Cited by 23
Mitochondrial dysfunction and apoptosis underlie the hepatotoxicity of perhexiline
Ren, Z., Chen, S., Seo, J., Guo, X., Li, D., Ning, B., & Guo, L. (2020) · Toxicology in Vitro · doi:10.1016/j.tiv.2020.104987 · Cited by 35
Fuente-Ballesteros, A., Brabenec, O., Tsagkaris, A. S., Ares, A. M., Hajšlová, J., & Bernal, J. (2023) · Journal of Food Composition and Analysis · doi:10.1016/j.jfca.2023.105758 · Cited by 24
Organoids in concert: engineering in vitro models toward enhanced fidelity
Chen, Z., Sugimura, R., Zhang, Y. S., Ruan, C., & Wen, C. (2024) · Aggregate · doi:10.1002/agt2.478 · Cited by 24
Lewis, J. H. (2013) · Pharmaceutical Medicine · doi:10.1007/s40290-013-0015-5 · Cited by 24
Cengiz, N., Kavak, S., Güzel, A., Özbek, H., Bektaş, H., Him, A., Erdoğan, E., & Balahoroğlu, R. (2012) · The Journal of Membrane Biology · doi:10.1007/s00232-012-9494-7 · Cited by 23
In vitro gene expression analysis of hepatotoxic drugs in rat primary hepatocytes
Suzuki, H., Inoue, T., Matsushita, T., Kobayashi, K., Horii, I., Hirabayashi, Y., & Inoue, T. (2008) · Journal of Applied Toxicology · doi:10.1002/jat.1328 · Cited by 23
Successful Drug Development Despite Adverse Preclinical Findings Part 2: Examples
Ettlin, R. A., Kuroda, J., Plassmann, S., Hayashi, M., & Prentice, D. E. (2010) · Journal of Toxicologic Pathology · doi:10.1293/tox.23.213 · Cited by 23
Nahar, B. L., Hossain, A. M., Islam, M. M., & Shaha, D. R. (2008) · Bangladesh Journal of Pharmacology · doi:10.3329/bjp.v1i2.488 · Cited by 25
Venlafaxine-induced cholestatic hepatitis: case report and review of literature.
Stadlmann, S., Portmann, S., Tschopp, S., & Terracciano, L. (2012) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31826af296 · Cited by 18
Wang, L., Huang, Q., Huang, Y., Xie, J., Qu, C. F., Chen, J., Zheng, L., Yi, T., Zeng, H., & Li, H.-L. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.05.016 · Cited by 23
Paniagua, A. C., & Amariles, P. (2018) · InTech eBooks · doi:10.5772/intechopen.72005 · Cited by 22
Direct and indirect effects of psychopharmacological treatment on the cardiovascular system
Kahl, K. G. (2018) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2018-0054 · Cited by 24
Zhang, Z.-H., Tang, J.-H., Zhan, Z.-L., Zhang, X., Wu, H., & Yan-ning, H. (2012) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(12)60044-3 · Cited by 23
Life-Threatening Serotonin Syndrome in a Patient With Chronic Heart Failure and CYP2D6*1/*5
Sato, A., Okura, Y., Minagawa, S., Ohno, Y., Fujita, S., Kondo, D., Hayashi, M., Komura, S., Kato, K., Hanawa, H., et al. (2004) · Mayo Clinic Proceedings · doi:10.4065/79.11.1444 · Cited by 23
Toxicidad hepática recurrente secundaria a metilprednisolona intravenosa
Fernández, M. R., Riesco, J. M., Moreira, V. F., Moreno, A., Román, A. L. S., Arranz, G., & Arbol, L. R. D. (2008) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082008001100010 · Cited by 26
Hepatotoxicity associated with the use of a fixed combination of chloroquine and proguanil
Wielgo-Polanin, R., Lagarce, L., Gautron, E., Diquet, B., & Lainé‐Cessac, P. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.04.019 · Cited by 23
Troglitazone prevents fatty changes of the liver in obese diabetic rats
Jia, D. M., Tabaru, A., Akiyama, T., Abe, S., & Otsuki, M. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02316.x · Cited by 24
Kum, L. C. C., Chan, W. W. L., Hui, H. H. Y., Wong, G. L., Ho, S. S. S., Sanderson, J. E., Yu, C., & FUNG, J. W. H. (2006) · Clinical Cardiology · doi:10.1002/clc.4960290705 · Cited by 23
Can Transcriptomic Profiles from Cancer Cell Lines Be Used for Toxicity Assessment?
Liu, Z., Zhu, L., Thakkar, S., Roberts, R. A., & Tong, W. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00288 · Cited by 31
Pádua, B. D. C., Rossoni, J. V., Magalhães, C. L. D. B., Chaves, M. M., Silva, M. E., Pedrosa, M. L., de Souza, G. H. B., Brandão, G. C., Rodrigues, I. V., de Lima, W. G., et al. (2014) · Mediators of Inflammation · doi:10.1155/2014/196598 · Cited by 22
Evaluation of mechanism of hepatotoxicity of leflunomide using albino wistar rats
Lodhi, L. (2013) · African Journal of Pharmacy and Pharmacology · doi:10.5897/ajpp2013.3517 · Cited by 22
Goda, K., Kobayashi, A., Takahashi, A., Takahashi, T., Saito, K., Maekawa, K., Saito, Y., & Sugai, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040810 · Cited by 22
Kim, K. M., & Ki, S. H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804274-8.00028-x · Cited by 22
Biomarkers of Drug-Induced Liver Toxicity
Neuman, M. G. (2019) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000610 · Cited by 25
Characteristics and Outcomes of Acetaminophen Overdose and Hepatotoxicity in Thailand
Pholmoo, N., & Bunchorntavakul, C. (2019) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2018.00066 · Cited by 24
Ghosh, A., Berger, I., Remien, C. H., & Mubayi, A. (2020) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2020.110559 · Cited by 25
Hadi, M., Chen, Y., Starokozhko, V., Merema, M. T., & Groothuis, G. M. M. (2012) · Chemical Research in Toxicology · doi:10.1021/tx300248j · Cited by 22
Metadata
- Authors
- Lee, W. M.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Lee, William M.
- ORCID
- Lee, William M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-07-31
- Volume
- 349
- Issue
- 5
- Pages
- 474-485
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3021092633
- Cited by
- 1,594
- References
- 180
- Citations by year
- 2026: 15 · 2025: 14 · 2024: 33 · 2023: 41 · 2022: 44 · 2021: 44 · 2020: 53 · 2019: 69 · 2018: 69 · 2017: 75 · 2016: 84 · 2015: 74 · 2014: 95 · 2013: 88 · 2012: 88
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- drug-induced liver injury, acute liver failure, idiosyncratic drug reactions, adverse drug reactions, drug approval, hepatotoxicity monitoring, liver transplantation
- MeSH terms
- Troglitazone, Anti-Inflammatory Agents, Non-Steroidal, Benzophenones, Bromobenzenes, Chromans, Pharmaceutical Preparations, Humans, Hypoglycemic Agents, Liver, Liver Cirrhosis, Liver Diseases, Liver Function Tests, Pharmacology, Thiazoles, Drug Approval, Thiazolidinediones, Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.